BYAH - Park Ha Biological... Stock Analysis | Stock Taper
Logo
Park Ha Biological Technology Co., Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co., Ltd. Ordinary Shares NASDAQ
$1.09 0.46% (+0.01)

Market Cap $738430
52w High $2074.50
52w Low $0.93
P/E 0
Volume 21.19K
Outstanding Shares 677.46K

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $1.29M $5.54M $-4.53M -352.26% $-7.61 $-4.34M
Q2-2025 $1.24M $20.9M $-19.84M -1.6K% $-33.76 $-19.7M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $3.79M $5.95M $1.96M $3.99M
Q2-2025 $1.35M $5.83M $1.58M $4.25M
Q4-2024 $547.5K $3.08M $1.58M $1.51M
Q2-2024 $931.97K $2.14M $1.07M $1.07M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-4.53M $-159.58K $2.69M $-97.83K $2.44M $-246.19K
Q2-2025 $-9.92M $245.43K $-3.26M $3.83M $803.79K $243.22K

5-Year Trend Analysis

A comprehensive look at Park Ha Biological Technology Co., Ltd. Ordinary Shares's financial evolution and strategic trajectory over the past five years.

+ Strengths

The company combines very strong product‑level margins, ample cash relative to its small debt load, and solid short‑term liquidity with a differentiated customer experience and a scalable hybrid store–franchise model. Its focus on sensitive and problematic skin, together with a broad product lineup and in‑store services, provides a clear brand story in a large and growing consumer market.

! Risks

Major risks center on sustained losses, a cost base that is outsized relative to current revenue, and dependence on external equity financing to maintain liquidity and fund expansion. Competitive pressures in the skincare space, limited visible proprietary technology, and a modest asset base amplify these concerns, while negative retained earnings underscore the history of capital consumption rather than creation.

Outlook

The outlook is that of a young, consumer‑facing brand still in the investment and scaling phase: financially fragile but with strategic plans to grow its footprint, deepen its product portfolio, and improve cost structure through vertical integration. Future performance will hinge on whether Park Ha can translate its high gross margins and customer‑centric model into sufficient sales growth and cost discipline to move toward sustainable cash generation, amid intense competition and evolving consumer behavior.